Neuroinflammation in Alzheimer's disease: Current evidence and future directions
Top Cited Papers
- 11 May 2016
- journal article
- review article
- Published by Wiley in Alzheimer's & Dementia
- Vol. 12 (6), 719-732
- https://doi.org/10.1016/j.jalz.2016.02.010
Abstract
Several attempts have been made to treat Alzheimer's disease (AD) using anti-amyloid strategies with disappointing results. It is clear that the "amyloid cascade hypothesis" alone cannot fully explain the neuronal damage in AD, as evidenced both by autopsy and imaging studies. Neuroinflammation plays a significant role in neurodegenerative diseases, whereas the debate is ongoing about its precise role, whether it is protective or harmful. In this review, we focus on the potential mechanism of glial activation and how local and systemic factors influence disease progression. We focus on neuroinflammation in AD, especially in the earliest stages, a vicious cycle of glial priming, release of pro-inflammatory factors, and neuronal damage. We review the evidence from imaging studies, regarding the temporal relationship between amyloid deposition and neuroinflammation, the influence of systemic inflammation on glial activation, both in acute and chronic stimulation and the relevance of inflammation as a diagnostic and therapeutic target.This publication has 89 references indexed in Scilit:
- Toll-like receptor 9 promoter polymorphism is associated with decreased risk of Alzheimer’s disease in Han ChineseJournal of Neuroinflammation, 2013
- TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s diseaseMolecular Neurodegeneration, 2013
- Microglia and macrophages of the central nervous system: the contribution of microglia priming and systemic inflammation to chronic neurodegenerationSeminars in Immunopathology, 2013
- Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive declineJCI Insight, 2012
- Genome-wide association study of Alzheimer's disease with psychotic symptomsMolecular Psychiatry, 2011
- Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's diseaseNature Genetics, 2011
- NSAIDs prevent, but do not reverse, neuronal cell cycle reentry in a mouse model of Alzheimer diseaseJCI Insight, 2009
- TNF-α and antibodies to periodontal bacteria discriminate between Alzheimer's disease patients and normal subjectsJournal of Neuroimmunology, 2009
- Carbon 11–Labeled Pittsburgh Compound B and Carbon 11–Labeled (R)-PK11195 Positron Emission Tomographic Imaging in Alzheimer DiseaseArchives of Neurology, 2009
- Amyloid Precursor Protein Expression Is Upregulated in Adipocytes in ObesityObesity, 2008